Whit Mayo
Stock Analyst at Leerink Partners
(3.21)
# 2,120
Out of 5,182 analysts
160
Total ratings
53.92%
Success rate
10.68%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $345 → $400 | $370.75 | +7.89% | 13 | Apr 22, 2026 | |
| ARDT Ardent Health | Maintains: Outperform | $16 → $15 | $9.98 | +50.30% | 3 | Mar 6, 2026 | |
| CLOV Clover Health Investments | Maintains: Market Perform | $3 → $2.5 | $2.65 | -5.66% | 5 | Mar 5, 2026 | |
| AHCO AdaptHealth | Maintains: Outperform | $13 → $12 | $13.04 | -7.98% | 12 | Feb 26, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Market Perform | $14 → $22 | $27.69 | -20.53% | 12 | Feb 26, 2026 | |
| EHAB Enhabit | Maintains: Market Perform | $9.5 → $14 | $13.74 | +0.44% | 3 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $255 → $264 | $185.35 | +42.43% | 15 | Feb 20, 2026 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $22.41 | -24.14% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $371.90 | -16.64% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $3.44 | -27.33% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $400 → $250 | $237.96 | +5.06% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $106.64 | -6.23% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $53.54 | -71.98% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $166.07 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $148.08 | -34.49% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $279.35 | +19.92% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $427.18 | -33.05% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $14.20 | +181.69% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $24.24 | +60.89% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $825 → $750 | $26.94 | +2,683.96% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $77.24 | +126.57% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $19.26 | -1.35% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $2.85 | +40.35% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $253.01 | -19.77% | 2 | May 1, 2018 |
UnitedHealth Group
Apr 22, 2026
Maintains: Outperform
Price Target: $345 → $400
Current: $370.75
Upside: +7.89%
Ardent Health
Mar 6, 2026
Maintains: Outperform
Price Target: $16 → $15
Current: $9.98
Upside: +50.30%
Clover Health Investments
Mar 5, 2026
Maintains: Market Perform
Price Target: $3 → $2.5
Current: $2.65
Upside: -5.66%
AdaptHealth
Feb 26, 2026
Maintains: Outperform
Price Target: $13 → $12
Current: $13.04
Upside: -7.98%
Acadia Healthcare Company
Feb 26, 2026
Maintains: Market Perform
Price Target: $14 → $22
Current: $27.69
Upside: -20.53%
Enhabit
Feb 23, 2026
Maintains: Market Perform
Price Target: $9.5 → $14
Current: $13.74
Upside: +0.44%
Tenet Healthcare
Feb 20, 2026
Maintains: Outperform
Price Target: $255 → $264
Current: $185.35
Upside: +42.43%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $22.41
Upside: -24.14%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $371.90
Upside: -16.64%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $3.44
Upside: -27.33%
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $237.96
Upside: +5.06%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $106.64
Upside: -6.23%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $53.54
Upside: -71.98%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $166.07
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $148.08
Upside: -34.49%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $279.35
Upside: +19.92%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $427.18
Upside: -33.05%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $14.20
Upside: +181.69%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $24.24
Upside: +60.89%
Nov 4, 2022
Maintains: Outperform
Price Target: $825 → $750
Current: $26.94
Upside: +2,683.96%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $77.24
Upside: +126.57%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $19.26
Upside: -1.35%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $2.85
Upside: +40.35%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $253.01
Upside: -19.77%